Browse our press releases on our Investors section, scroll down to read the latest from our teams around the world, and be inspired by our Podders.
PRESS RELEASES
Features
New Markets for Omnipod® 5: Our growth momentum continues to build as the Omnipod 5 Automated Insulin Delivery (AID) System recently launched in four more countries—Australia, Belgium, Canada, and Switzerland. As the #1 insulin pump for new pump users in Europe and the #1 prescribed AID system in the U.S., Omnipod 5 continues to transform diabetes management globally, delivering real-world benefits that improve the lives of people with diabetes.
Insulet Shines at ATTD 2025: Insulet exhibited and presented at the Advanced Technologies and Treatments for Diabetes (ATTD) congress in Amsterdam, Netherlands this spring. From interactive experiences and eye-catching displays in the Omnipod booth, to an impressive symposium featuring Omnipod 5 clinical data, Team Insulet created a lasting impact on the international community of diabetes experts, clinicians, researchers, and industry professionals.
Connection and Support: Insulet hosted its first global community event, “All for One,” in Amsterdam, bringing together its largest assembly of people with diabetes ever. The participants were from six different global markets and featured an array of diabetes management technologies. The shared experiences and personal stories educated and enlightened, while highlighting how Omnipod can bring people together and foster community spirit.
Podder Talk™ Blog
For Media Inquiries, please reach out to:
Angela Geryak Wiczek
Senior Director, Corporate Communications
[email protected]
For Investor Relations, please reach out to:
June Lazaroff
Senior Director, Investor Relations
[email protected]